Quick Links
Downloads
Recordings
Schedule
** All time indicated below are Pacific Time **
| Friday, December 2, 2022 | |||
| 7:00 a.m. | Registration and Continental Breakfast | ||
| 8:10 a.m. | Welcome and Symposium Overview | Peter Ganz, MD | |
| Session: Frontiers in Cardiology: Genetics, Artificial Intelligence and Deep Empathy | Chair: Priscilla Hsue, MD | ||
| 8:15 a.m. | The Mind-Heart Connection: Stress and Trauma as Cardiovascular Risk Factors | Ahmed Tawakol, MD | Slides |
| 8:55 a.m. | Artificial Intelligence in Cardiology | Geoff Tison, MD, MPH | Slides |
| 9:35 a.m. | Ascending Thoracic Aortic Aneurysms: Evaluation, Management and Genetic Testing | Lisa Wilsbacher, MD, PhD | Slides |
| 10:15 a.m. | Coffee Break | ||
| 10:30 a.m. | Update on Transthyretin Amyloidosis | Mandar Aras, MD, PhD | Slides |
| 11:10 a.m. | Gene Targeting for Cardiometabolic Diseases – Where are We? | John Chorba, MD | Slides |
| 11:50 a.m. | Elliot Rapaport Keynote Lecture: High Performance with Deep Empathy Medicine | Eric Topol, MD | |
| 12:40 a.m. | Lunch (on Your Own) | ||
| Session: State-of-the-Art: Cardiovascular Interventions | Chair: Lucas Zier, MD, MS | ||
| 2:00 p.m. | New Approaches to Pulmonary Embolism | Gregory Piazza, MD, MS | Slides |
| 2:40 p.m. | Physiological Assessment of Coronary Stenosis Severity by CT Angiography and in the Cath Lab | William Fearon, MD | Slides |
| 3:20 p.m. | Expanding Options in the Management of Endocarditis | Amy Fiedler, MD, MS | Slides |
| Ann Bolger, MD | Slides | ||
| 4:00 p.m. | Coffee Break | ||
| 4:15 p.m. | Surgical Approaches to Advanced Heart Failure | Jason Smith, MD | Slides |
| 4:55 p.m. | Revascularization in Stable Coronary Disease: Sorting through the Evidence | Jeffrey Zimmet, MD, PhD | Slides |
| 5:35 p.m. | Adjourn | ||
| Saturday, December 3, 2022 | |||
| 7:30 a.m. | Continental Breakfast | ||
| 8:05 a.m. | Announcements | Peter Ganz, MD | |
| Session: Advances and Controversies in Electrophysiology | Chair: Nora Goldschlager, MD | ||
| 8:10 a.m. | Defining Sudden Cardiac Death in 2022 | Zian Tseng, MD, MAS | |
| 8:50 a.m. | ECG Findings Suggesting High Arrhythmic Risk | Melvin Scheinman, MD | Slides |
| 9:30 a.m. | Debate: AFib Ablation Should be First Line Therapy in Patients with Symptomatic AFib | Adam Lee, MD | Slides |
| Tommy Dewland, MD | Slides | ||
| 10:10 a.m. | Coffee Break | ||
| 10:25 a.m. | Advances in Cardiac Imaging for Arrhythmia Etiology, Prognosis and Therapy | Edward Gerstenfeld, MD, MS | Slides |
| 11:05 a.m. | The Effect of Alcohol, Exercise and Lifestyle on Atrial Fibrillation | Gregory Marcus, MD, MAS | Slides |
| 11:45 a.m. | Interventions for Novel/Genetic Arrhythmias | Vasanth Vedantham, MD, PhD | Slides |
| 12:25 p.m | Debate: Prophylactic Primary Prevention ICD in Dilated Cardiomyopathy with Heart Failure | Byron Lee, MD, MS | Slides |
| Joshua Moss, MD, MS | Slides | ||
| 1:05 p.m. | Lunch (on your own) | ||
| Session: Managing Heart Failure | Chair: Jonathan Davis, MD, MPHS | ||
| 2:20 p.m. | Cardiogenic Shock | Jaya Mallidi, MD | Slides |
| 3:00 p.m. | New Heart Failure Guidelines for HFrEF | Jonathan Davis, MD, MPHS | |
| 3:40 p.m. | New Heart Failure Guidelines for HFpEF | Jonathan Davis, MD, MPHS | |
| 4:20 p.m. | Coffee Break | ||
| 4:35 p.m. | Polypharmacy and Medication Costs for Guideline Directed Medical Therapy for HFrEF | Anusha McNamara, PharmD | Slides |
| Rose Pavlakos, PharmD | |||
| 5:15 p.m. | Remote Monitoring of Patients with Cardiovascular Diseases | Liviu Klein, MD, MS | Slides |
| 5:55 p.m. | Adjourn | ||
| Sunday, December 4, 2022 | |||
| 7:30 a.m. | Continental Breakfast | ||
| 8:00 a.m. | Announcements | Peter Ganz, MD | |
| Session: Managing Cardiovascular Risk | Chair: Binh An P. Phan, MD | ||
| 8:05 a.m. | The Effect of Salt and Salt Substitutes Consumption on Clinical Outcomes in Hypertension and Heart Failure | Michael Crawford, MD | Slides |
| 8:45 a.m. | Managing Cardiovascular Risk in the Elderly | Carlin Long, MD | Slides |
| 9:25 a.m. | Current Cholesterol Guidelines: Controversies and Agreements | Peter Ganz, MD | Slides |
| 10:05 a.m. | Where Are We with Non-Statin Lipid Modifying Therapy? | Jorge Plutzky, MD | Slides |
| 10:45 a.m. | Management of Cardiovascular Risk and Chronic Kidney Disease Progression with Patients with Diabetes | Lisa Murphy, MD, PhD | Slides |
| 11:25 a.m. | Impact of Air Pollution on Cardiovascular Outcomes | Karol Watson, MD, PhD | Slides |
| 12:05 p.m. | Adjourn | ||